carbidopa and Movement Disorders

carbidopa has been researched along with Movement Disorders in 71 studies

Research

Studies (71)

TimeframeStudies, this research(%)All Research%
pre-199039 (54.93)18.7374
1990's20 (28.17)18.2507
2000's6 (8.45)29.6817
2010's5 (7.04)24.3611
2020's1 (1.41)2.80

Authors

AuthorsStudies
Artusi, CA; Imbalzano, G; Ledda, C; Lopiano, L; Montanaro, E; Rizzone, MG; Romagnolo, A; Zibetti, M1
Băjenaru, O; Buraga, I; Constantinescu, A; Ene, A; Mureşan, DF; Perju-Dumbrava, L; Popescu, BO; Popescu, CD; Sabău, M; Simu, M; Szász, JA1
Hattori, N1
Delgado, MR; Donovan, MA; Jou, RL; Kang, PB; Kim, SY; Neilan, EG; Wu, BL1
Dugan, EA; Hayashi, Y; Jacob-Vadakot, S; McBride, S; Murray, M; Olexa, R; Shumsky, JS; Simansky, K1
Fisher, R; Jackson, MJ; Jenner, P; Rose, S; Tayarani-Binazir, KA; Zoubiane, G1
Armstrong, J; Artuch, R; Barredo-Valderrama, E; Campistol, J; Castro de Castro, P; Cormand, B; Garcia-Cazorla, A; Ormazabal, A; Serrano, M; Toma, C1
Gadkary, CA; Mummaneni, PV; Quinones-Hinojosa, A; Rosenberg, WS1
Blau, N; Connolly, MB; Demos, MK; Hyland, K; Lillquist, Y; Makhseed, N; Vallance, HD; Waters, PJ1
Crucian, GP; Drago, V; Foster, PS; Heilman, KM; Skidmore, F; Skoblar, BM1
Albizzati, MG; Bassi, S; Frattola, L; Spano, PF; Trabucchi, M1
Ballard, P; Langston, JW1
Casey, DE1
Bentlage, C; Björklund, A; Nikkhah, G; Olsson, M1
Donat, J; Gerrard, JW; Richardson, JS1
Brin, IL; Drozdov, AZ; Filatova, TS; Kogan, BM; Kovaleva, IA1
Broe, GA; Hely, MA; Margrie, S; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM1
Atchison, PR; Frackowiak, RS; Marsden, CD; Thompson, PD1
Bennett, JP; Schuh, LA1
Imai, H; Kondo, T; Nakamura, T; Narabayashi, H1
Horstink, MW; Jansen, EN; Roos, RA; Wolters, EC1
Date, ES; Schwartz, M; Seibel, MO; Zeiner, H1
Caraceni, T; Fetoni, V; Geminiani, GC; Genitrini, S; Giovannini, P; Girotti, F; Parati, EA; Soliveri, P; Testa, D1
Campistol, J; Garaizar, C; Prats, JM1
Burns, RS; Davis, TL; Roznoski, M1
Dubinsky, R; Hubble, JP; Koller, WC; Lyons, K; McGuire, D; Pahwa, R1
Carvey, PM; Goetz, CG; Ling, ZD; Niederman, F; Pappert, EJ; Stebbins, GT1
Carter, JH; Lea, ES; Nutt, JG; Woodward, WR1
Blaney, TJ; Chandonait, SE; Emerich, DF; Lindner, MD; Mullins, TD; Plone, MA; Sherman, SS; Stott, JA; Winn, SR1
Gordin, A; Jenner, P; Marsden, CD; Smith, LA1
Ellis, KL; Speed, J1
Hempel, AG; Maaty, MA; Sage, JI; Wagner, ML1
Ahangar, B; Burke, DT; Chae, H; Frates, EP1
Elsworth, JD; Kohout, LJ; Lees, AJ; Sandler, M; Shaw, KM; Stern, GM; Youdim, MB1
Sears, ES1
Fahn, S2
Anders, TF; Barchas, JD; Berger, PA; Cann, HM; Ciaranello, RD1
Adamkov, J; Drobný, M; Fundárek, J; Svaleková, A1
Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM1
Fisher, MA; Milner-Brown, HS; Weiner, WJ1
Hayek, J1
Duvoisin, RC1
Gabreëls, FJ; Joosten, EM; Keyser, A; Korten, JJ1
Marsden, CD; Parkes, JD; Tarsy, D1
Goodgold, A; Jonas, S; Leibowitz, M; Lieberman, A1
Bell-Midura, M; Cotzias, GC; Mendez, JS; Papavasiliou, PS; Tolosa, ES1
Kishikawa, H; Ohmoto, T1
Marsden, CD; Pires, M; Quinn, NP; Scaravilli, F; Steiger, MJ1
Löscher, W; Pagliusi, SR1
Butler, IJ; Caskey, TC; Jankovic, J; Stout, JT1
Deleu, D; Ebinger, G; Jacques, M; Michotte, Y1
Gilley, DW; Goetz, CG; Klawans, HL; Tanner, CM1
Dickins, QS; Dobson, J; Rodnitzky, RL1
Bush, DF; Hutton, JT; Liss, CL; Morris, JL; Reines, S; Smith, ME1
Reynolds, CM; Riklan, M; Stellar, S1
Simpson, GM; Stephanos, MJ; Yadalam, KG1
Bioulac, B; Doudet, D; Gross, C; Lebrun-Grandié, P1
Agnoli, A; Brughitta, G; Ruggieri, S; Stocchi, F1
Hoerning, E; Kaplan, PE; Sohn, DG1
Bakker, K; Bruno, G; Chase, TN; Ruggieri, S; Tamminga, CA1
Calne, DB; Jaffe, M; Larsen, TA; LeWitt, PA; Newman, RP1
Benvenuti, F; Bindi, A; Costantini, S; De Scisciolo, G; Pantaleo, T; Rossi, L; Zappoli, R1
Chase, TN; Woods, AC1
Glasgow, GL; Henley, JW; Willoughby, EW1
Cotzias, GC; Mena, I; Papavasiliou, PS1
Markham, CH1
Andrews, CJ; Somerville, B1
Brody, JA; Chase, TN; Holden, EM1
Duvoisin, RC; Marsden, CD1

Reviews

4 review(s) available for carbidopa and Movement Disorders

ArticleYear
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:9

    Topics: Carbidopa; COVID-19; COVID-19 Vaccines; Deep Brain Stimulation; Drug Combinations; Humans; Immunization, Secondary; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Treatment Outcome; Vaccination

2022
Movement disorders: advances in 2015.
    The Lancet. Neurology, 2016, Volume: 15, Issue:1

    Topics: Animals; Antiparkinson Agents; Carbidopa; DNA-Binding Proteins; Drug Combinations; Humans; Levodopa; Mitochondrial Proteins; Movement Disorders; Parkinson Disease; Transcription Factors

2016
Entacapone/levodopa/carbidopa combination tablet: Stalevo.
    Drugs in R&D, 2003, Volume: 4, Issue:5

    Topics: Administration, Oral; Antiparkinson Agents; Carbidopa; Catechols; Clinical Trials as Topic; Drug Combinations; Humans; Levodopa; Movement Disorders; Nitriles; Parkinson Disease; Tablets

2003
The syndrome of gait ignition failure: a report of six cases.
    Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:3

    Topics: Aged; Benserazide; Brain; Carbidopa; Diagnosis, Differential; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Neurologic Examination; Parkinson Disease; Syndrome; Tomography, X-Ray Computed

1993

Trials

18 trial(s) available for carbidopa and Movement Disorders

ArticleYear
Greater motor improvement in right hemibody Parkinson's patients after dopaminergic medications.
    Parkinsonism & related disorders, 2009, Volume: 15, Issue:1

    Topics: Aged; Analysis of Variance; Carbidopa; Dopamine Agents; Female; Functional Laterality; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease

2009
The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:8

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prevalence; Prospective Studies; Severity of Illness Index; Survival Analysis; Treatment Failure

1994
Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group.
    Advances in neurology, 1993, Volume: 60

    Topics: Antiparkinson Agents; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parkinson Disease

1993
Acute effects of COMT inhibition on L-DOPA pharmacokinetics in patients treated with carbidopa and selegiline.
    Clinical neuropharmacology, 1995, Volume: 18, Issue:4

    Topics: Aged; Antiparkinson Agents; Benzophenones; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Movement Disorders; Nitrophenols; Parkinson Disease; Selegiline; Tolcapone

1995
Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa.
    Neurology, 1996, Volume: 46, Issue:4

    Topics: Aged; Carbidopa; Circadian Rhythm; Cross-Over Studies; Delayed-Action Preparations; Dihydroxyphenylalanine; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease

1996
Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation.
    Neurology, 1996, Volume: 47, Issue:6

    Topics: Adult; Aged; Carbidopa; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders

1996
Pharmacoeconomic analysis of using Sinemet CR over standard Sinemet in parkinsonian patients with motor fluctuations.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prospective Studies

1998
Deprenyl in Parkinson's disease.
    Lancet (London, England), 1977, Oct-15, Volume: 2, Issue:8042

    Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Phenethylamines

1977
Madopar versus sinemet. A clinical study on their effectiveness.
    European neurology, 1975, Volume: 13, Issue:2

    Topics: Adult; Aged; Benserazide; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Serine

1975
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
    Journal of neurology, neurosurgery, and psychiatry, 1975, Volume: 38, Issue:4

    Topics: Aged; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Promethazine

1975
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease.
    Neurology, 1975, Volume: 25, Issue:10

    Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Mental Disorders; Middle Aged; Movement Disorders; Parkinson Disease

1975
Treatment of Parkinson's disease with aporphines. Possible role of growth hormone.
    The New England journal of medicine, 1976, Mar-11, Volume: 294, Issue:11

    Topics: Administration, Oral; Aged; Apomorphine; Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Growth Hormone; Humans; Kidney; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Secretory Rate

1976
Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease.
    Neurology, 1989, Volume: 39, Issue:11 Suppl 2

    Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Movement Disorders; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic

1989
Double-blind carbidopa/levodopa and placebo study in tardive dyskinesia.
    Journal of clinical psychopharmacology, 1988, Volume: 8, Issue:4 Suppl

    Topics: Adult; Aged; Antipsychotic Agents; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Random Allocation

1988
Caerulein treatment of Parkinson's disease.
    Clinical neuropharmacology, 1985, Volume: 8, Issue:3

    Topics: Adult; Aged; Carbidopa; Ceruletide; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease

1985
Motor function in the normal aging population: treatment with levodopa.
    Neurology, 1985, Volume: 35, Issue:4

    Topics: Aged; Aging; Carbidopa; Dopamine; Drug Combinations; Humans; Levodopa; Middle Aged; Movement; Movement Disorders; Parkinson Disease

1985
L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease.
    Australian and New Zealand journal of medicine, 1974, Volume: 4, Issue:4

    Topics: Aged; Blood Pressure; Carbidopa; Clinical Trials as Topic; Depression, Chemical; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Placebos; Posture; Vomiting

1974
Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    The Medical journal of Australia, 1974, Mar-23, Volume: 1, Issue:12

    Topics: Adult; Aged; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hydrazines; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Placebos

1974

Other Studies

49 other study(ies) available for carbidopa and Movement Disorders

ArticleYear
The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience.
    Journal of neural transmission (Vienna, Austria : 1996), 2016, Volume: 123, Issue:4

    Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gastric Bypass; Gels; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Quality of Life; Retrospective Studies; Romania

2016
Response of motor complications in Cockayne syndrome to carbidopa-levodopa.
    Archives of neurology, 2008, Volume: 65, Issue:8

    Topics: Adolescent; Carbidopa; Cockayne Syndrome; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Movement Disorders

2008
5-HT precursor loading, but not 5-HT receptor agonists, increases motor function after spinal cord contusion in adult rats.
    Experimental neurology, 2010, Volume: 221, Issue:1

    Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Cervical Vertebrae; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Enzyme Inhibitors; Exercise Test; Exploratory Behavior; Female; Fenfluramine; Hindlimb; Laminectomy; Motor Activity; Movement Disorders; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Spinal Cord Injuries; Stereotyped Behavior; Time Factors; Tremor; Up-Regulation

2010
The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
    European journal of pharmacology, 2010, Jun-10, Volume: 635, Issue:1-3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Callithrix; Carbidopa; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Female; Levodopa; Male; Methyldopa; Motor Activity; Movement Disorders

2010
Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype.
    Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:8

    Topics: Antiparkinson Agents; Carbidopa; DNA Mutational Analysis; Drug Combinations; Female; Homovanillic Acid; Humans; Infant; Levodopa; Movement Disorders; Phenotype; Sequence Deletion; Tyrosine 3-Monooxygenase; Video Recording

2011
Split spinal cord malformation in an elderly patient: case report.
    Surgical neurology, 2004, Volume: 61, Issue:2

    Topics: Aged; Anticonvulsants; Antiparkinson Agents; Carbidopa; Clonazepam; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Low Back Pain; Magnetic Resonance Imaging; Movement Disorders; Spinal Dysraphism; Tomography, X-Ray Computed

2004
6-pyruvoyl-tetrahydropterin synthase deficiency with mild hyperphenylalaninemia.
    Annals of neurology, 2005, Volume: 58, Issue:1

    Topics: 5-Hydroxytryptophan; Biopterins; Carbidopa; Cerebral Palsy; Child; Developmental Disabilities; Diagnostic Errors; Dopamine Agents; Female; Humans; Levodopa; Movement Disorders; Phenylalanine; Phenylketonurias; Phosphorus-Oxygen Lyases; Seizures

2005
Treatment of dyskinetic and dystonic disorders with CF 25-397: clinical and pharmacological aspects.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Aged; Carbidopa; Dystonia; Ergolines; Female; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease

1980
Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Carbidopa; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Parkinson Disease, Secondary; Pyridines

1984
Pharmacology of blepharospasm-oromandibular dystonia syndrome.
    Neurology, 1980, Volume: 30, Issue:7 Pt 1

    Topics: Aged; Benztropine; Blepharospasm; Carbidopa; Deanol; Drug Therapy, Combination; Electromyography; Eyelid Diseases; Humans; Jaw Diseases; Levodopa; Male; Middle Aged; Movement Disorders; Syndrome

1980
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1995, Volume: 15, Issue:5 Pt 2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Apomorphine; Brain Tissue Transplantation; Carbidopa; Dextroamphetamine; Disease Models, Animal; Dopamine; Dopamine Agonists; Ergolines; Female; Fetal Tissue Transplantation; Forelimb; Functional Laterality; Levodopa; Motor Activity; Movement Disorders; Norepinephrine; Oxidopamine; Parkinson Disease; Quinpirole; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Transplantation, Heterotopic

1995
Neuropharmacological evaluation of movement disorders that are adverse reactions to specific foods.
    The International journal of neuroscience, 1994, Volume: 76, Issue:1-2

    Topics: Adult; Animals; Aspartame; Carbidopa; Coffee; Diazepam; Double-Blind Method; Eggs; Female; Food Hypersensitivity; Haloperidol; Humans; Male; Milk; Milk Hypersensitivity; Movement Disorders; Propranolol; Single-Blind Method; Theophylline; Videotape Recording

1994
[Catecholamines and the dopamine-beta-hydroxylase activity of the blood plasma in motor pathology in children: the role of central and peripheral mechanisms].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1994, Volume: 94, Issue:3

    Topics: Adolescent; Carbidopa; Catecholamines; Child; Chromatography, High Pressure Liquid; Dopamine Agonists; Dopamine beta-Hydroxylase; Drug Combinations; Female; Humans; Levodopa; Male; Movement Disorders; Spectrophotometry

1994
Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease.
    Neurology, 1993, Volume: 43, Issue:8

    Topics: Aged; Antiparkinson Agents; Carbidopa; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Tyrosine

1993
Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
    Advances in neurology, 1993, Volume: 60

    Topics: Benserazide; Carbidopa; Diagnosis, Differential; Drug Therapy, Combination; Humans; Levodopa; Motor Activity; Movement Disorders; Neurologic Examination; Ocular Motility Disorders; Parkinson Disease; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive

1993
Rehabilitation of patients with Hallervorden-Spatz syndrome.
    Archives of physical medicine and rehabilitation, 1993, Volume: 74, Issue:3

    Topics: Activities of Daily Living; Adult; Carbidopa; Drug Therapy, Combination; Exercise Therapy; Humans; Levodopa; Male; Movement Disorders; Pantothenate Kinase-Associated Neurodegeneration; Patient Care Team

1993
Response to L-DOPA in multiple system atrophy.
    Clinical neuropharmacology, 1993, Volume: 16, Issue:2

    Topics: Adult; Aged; Carbidopa; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement; Movement Disorders; Muscle Rigidity; Olivopontocerebellar Atrophies; Parkinson Disease; Tremor

1993
Benign paroxysmal tonic upgaze of childhood with ataxia. A neuro-ophthalmological syndrome of familial origin?
    Developmental medicine and child neurology, 1993, Volume: 35, Issue:5

    Topics: Age Factors; Ataxia; Carbidopa; Eye Movements; Family; Humans; Infant; Levodopa; Male; Movement Disorders; Ocular Motility Disorders; Posture; Sleep; Syndrome

1993
Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:3

    Topics: Adult; Aged; Amino Acids; Antiparkinson Agents; Brain; Carbidopa; Circadian Rhythm; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Severity of Illness Index; Time Factors

1997
Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats.
    Experimental neurology, 1997, Volume: 145, Issue:1

    Topics: Administration, Oral; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Carbidopa; Cell Transplantation; Disease Models, Animal; Dopamine; Drug Combinations; Drug Synergism; Levodopa; Male; Movement Disorders; Neostriatum; Parkinson Disease, Secondary; PC12 Cells; Rats; Rats, Sprague-Dawley; Rotation

1997
Entacapone enhances levodopa-induced reversal of motor disability in MPTP-treated common marmosets.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Carbidopa; Catechols; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Female; Levodopa; Male; Movement Disorders; Nitriles; Severity of Illness Index

1997
Pharmacologic management of movement disorder after midbrain haemorrhage.
    Brain injury, 1998, Volume: 12, Issue:7

    Topics: Activities of Daily Living; Adult; Brain Neoplasms; Carbidopa; Cavernous Sinus; Central Nervous System Stimulants; Cerebral Hemorrhage; Dopamine Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hemangioma, Cavernous; Humans; Levodopa; Male; Mesencephalon; Methamphetamine; Movement Disorders; Substance-Related Disorders

1998
Post-stroke violent adventitial movement responsive to levo-dopa/carbi-dopa therapy.
    Brain injury, 2001, Volume: 15, Issue:10

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Basal Ganglia; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Movement Disorders; Stroke; Treatment Outcome; Tremor

2001
Therapeutics of disordered movement.
    American family physician, 1977, Volume: 16, Issue:3

    Topics: Carbidopa; Chorea; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Movement Disorders; Parasympatholytics; Parkinson Disease; Receptors, Cholinergic; Receptors, Dopamine; Tremor

1977
New approaches in the management of hyperkinetic movement disorders.
    Advances in experimental medicine and biology, 1977, Volume: 90

    Topics: 5-Hydroxytryptophan; Carbidopa; Chorea; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Myoclonus; Propranolol; Receptors, Dopamine; Torticollis; Tranquilizing Agents; Tremor

1977
Further observations on the use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome.
    Neuropadiatrie, 1978, Volume: 9, Issue:2

    Topics: 5-Hydroxytryptophan; Carbidopa; Child; Drug Therapy, Combination; Humans; Hydrazines; Lesch-Nyhan Syndrome; Male; Movement Disorders; Self Mutilation; Sleep; Wakefulness

1978
[Therapy of rigidity and hypokinesis in old age using Sinemet].
    Ceskoslovenska neurologie a neurochirurgie, 1979, Volume: 42, Issue:3

    Topics: Aged; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Muscle Rigidity; Parkinson Disease, Postencephalitic; Trihexyphenidyl

1979
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
    Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:12

    Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis

1977
Electrical properties of motor units in Parkinsonism and a possible relationship with bradykinesia.
    Journal of neurology, neurosurgery, and psychiatry, 1979, Volume: 42, Issue:1

    Topics: Action Potentials; Adult; Aged; Carbidopa; Electromyography; Forearm; Gait; Hand; Humans; Levodopa; Male; Middle Aged; Motor Skills; Movement Disorders; Muscle Contraction; Muscles; Neuromuscular Junction; Parkinson Disease; Recruitment, Neurophysiological

1979
[Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
    Schweizerische medizinische Wochenschrift, 1977, Apr-09, Volume: 107, Issue:14

    Topics: Carbidopa; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Parkinson Disease; Psychoses, Substance-Induced

1977
Problems in the treatment of Parkinsonism.
    Advances in experimental medicine and biology, 1977, Volume: 90

    Topics: Antiparkinson Agents; Arteriosclerosis; Carbidopa; Diagnosis, Differential; Drug Combinations; Eye Manifestations; Humans; Levodopa; Mental Disorders; Movement Disorders; Parasympatholytics; Paresthesia; Parkinson Disease; Vision Disorders

1977
L-dopa therapy combined with peripheral decarboxylase inhibitor (MK-486) in Parkinsonism.
    Folia psychiatrica et neurologica japonica, 1975, Volume: 29, Issue:1

    Topics: Adult; Aged; Animals; Carbidopa; Carboxy-Lyases; Cats; Dopamine; Drug Therapy, Combination; Female; Humans; Hydrazines; Injections, Intraperitoneal; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease

1975
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration.
    Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:1

    Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Carbidopa; Central Nervous System Diseases; Chorea; Diagnosis, Differential; Drug Combinations; Female; Humans; Levodopa; Movement Disorders; Nerve Degeneration; Parkinson Disease; Spinal Cord

1992
Development of tolerance to the wet-dog shake behaviour but not the increase in seizure threshold induced by L-5-hydroxytryptophan during continued treatment in rats.
    Psychopharmacology, 1985, Volume: 86, Issue:1-2

    Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Body Weight; Brain Chemistry; Carbidopa; Drug Interactions; Drug Tolerance; Female; Hydroxyindoleacetic Acid; Movement Disorders; Rats; Rats, Inbred Strains; Seizures; Serotonin

1985
Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.
    Annals of neurology, 1988, Volume: 23, Issue:5

    Topics: Carbidopa; Catecholamines; Child; Child, Preschool; Fluphenazine; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lesch-Nyhan Syndrome; Levodopa; Male; Methoxyhydroxyphenylglycol; Movement Disorders; Self Mutilation; Tetrabenazine

1988
Clinical and pharmacokinetic evaluation of controlled-release levodopa/carbidopa (CR-4) in parkinsonian patients with severe motor fluctuations: a six month follow-up study.
    Clinical neurology and neurosurgery, 1989, Volume: 91, Issue:4

    Topics: Adult; Aged; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease

1989
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa.
    Neurology, 1989, Volume: 39, Issue:11 Suppl 2

    Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease; Psychomotor Performance

1989
Long-term clinical efficacy of Sinemet CR in patients with Parkinson's disease.
    Neurology, 1989, Volume: 39, Issue:11 Suppl 2

    Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease

1989
Correlates of memory in Parkinson's disease.
    The Journal of nervous and mental disease, 1989, Volume: 177, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amantadine; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Memory; Memory Disorders; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease

1989
[A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1985, Volume: 179, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Carbidopa; Disease Models, Animal; Drug Combinations; Electromyography; Levodopa; Macaca mulatta; Movement Disorders; Parkinson Disease, Secondary; Pyridines

1985
Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
    Journal of neural transmission. Supplementum, 1986, Volume: 22

    Topics: Administration, Oral; Adult; Aged; Carbidopa; Domperidone; Ergolines; Female; Humans; Infusions, Intravenous; Levodopa; Lisuride; Male; Middle Aged; Movement Disorders; Parkinson Disease

1986
Carbidopa-levodopa therapy for movement disorders.
    Archives of physical medicine and rehabilitation, 1987, Volume: 68, Issue:10

    Topics: Basal Ganglia Diseases; Carbidopa; Craniocerebral Trauma; Drug Therapy, Combination; Humans; Levodopa; Movement Disorders

1987
Auditory and somatosensory evoked potentials (AEPs and SEPs) and ballistic movements in Parkinson disease.
    Italian journal of neurological sciences, 1985, Volume: 6, Issue:3

    Topics: Aged; Carbidopa; Drug Therapy, Combination; Electromyography; Evoked Potentials, Auditory; Evoked Potentials, Somatosensory; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease

1985
M.I.F.: effect on levodopa dyskinesias in man.
    Lancet (London, England), 1973, Sep-01, Volume: 2, Issue:7827

    Topics: Antiparkinson Agents; Carbidopa; Carboxy-Lyases; Decarboxylation; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Humans; Melanocyte-Stimulating Hormones; Methylation; Movement Disorders; Parkinson Disease

1973
Short- and long-term approaches to the "on-off" phenomenon.
    Advances in neurology, 1974, Volume: 5

    Topics: Apomorphine; Carbidopa; Dietary Proteins; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Movement Disorders; Parkinson Disease; Time Factors

1974
The "on-off" side effect of L-DOPA.
    Advances in neurology, 1974, Volume: 5

    Topics: Age Factors; Amitriptyline; Aromatic Amino Acid Decarboxylase Inhibitors; Athetosis; Carbidopa; Catechol O-Methyltransferase Inhibitors; Chlordiazepoxide; Chorea; Desipramine; Diazepam; Dietary Proteins; Enzyme Inhibitors; Female; Humans; Imipramine; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Physical Exertion; Picolinic Acids; Prochlorperazine; Sex Factors; Stress, Psychological

1974
Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis.
    Archives of neurology, 1973, Volume: 29, Issue:5

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Carbidopa; Dementia; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease

1973
Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi.
    Brain research, 1974, May-10, Volume: 71, Issue:1

    Topics: Animals; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Disease Models, Animal; Disulfiram; Dose-Response Relationship, Drug; Drug Synergism; Methyldopa; Mice; Movement Disorders; Parkinson Disease; Phenoxybenzamine; Pimozide; Reserpine

1974
"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
    Neurology, 1974, Volume: 24, Issue:5

    Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydrazines; Injections, Intramuscular; Male; Methyldopa; Middle Aged; Movement Disorders; Parkinson Disease; Pyridoxine

1974